GlaxoSmithKline Plc in Soft Drinks (United Kingdom)
In 2013, the company sold its brands Ribena and Lucozade to Japanese giant Suntory Holdings for an estimated £1.35 million and, from 2014, will focus on restructuring its operations and strengthening its other brands in order to grow stronger in its core business: Consumer healthcare.
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Asian Speciality Drinks, Bottled Water, Carbonates, Concentrates, Juice, RTD Coffee, RTD Tea, Sports and Energy Drinks.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Asian Speciality Drinks, Bottled Water, Carbonates, Concentrates, Juice, RTD Coffee, RTD Tea, Sports and Energy Drinks.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Soft Drinks market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline Plc: Key Facts
Summary 2 GlaxoSmithKline Plc: Group Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 GlaxoSmithKline Plc: Competitive Position 2013
Key Facts
Summary 1 GlaxoSmithKline Plc: Key Facts
Summary 2 GlaxoSmithKline Plc: Group Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 GlaxoSmithKline Plc: Competitive Position 2013